Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Prediabetic State HELP
Based on 3,632 articles published since 2008
||||

These are the 3632 published articles about Prediabetic State that originated from Worldwide during 2008-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
1 Guideline Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. 2016

Chamberlain, James J / Rhinehart, Andrew S / Shaefer, Charles F / Neuman, Annie. · ·Ann Intern Med · Pubmed #26928912.

ABSTRACT: DESCRIPTION: The American Diabetes Association (ADA) published the 2016 Standards of Medical Care in Diabetes (Standards) to provide clinicians, patients, researchers, payers, and other interested parties with the components of diabetes care, general treatment goals, and tools to evaluate the quality of care. METHODS: The ADA Professional Practice Committee performed a systematic search on MEDLINE to revise or clarify recommendations based on new evidence. The committee assigns the recommendations a rating of A, B, or C, depending on the quality of evidence. The E rating for expert opinion is assigned to recommendations based on expert consensus or clinical experience. The Standards were reviewed and approved by the Executive Committee of the ADA Board of Directors, which includes health care professionals, scientists, and laypersons. Feedback from the larger clinical community was incorporated into the 2016 revision. RECOMMENDATIONS: The synopsis focuses on 8 key areas that are important to primary care providers. The recommendations highlight individualized care to manage the disease, prevent or delay complications, and improve outcomes.

2 Guideline CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. 2016

Garber, Alan J / Abrahamson, Martin J / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / DeFronzo, Ralph A / Einhorn, Daniel / Fonseca, Vivian A / Garber, Jeffrey R / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Henry, Robert R / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul D / Umpierrez, Guillermo E / Anonymous6890853 / Anonymous6900853. · ·Endocr Pract · Pubmed #26731084.

ABSTRACT: -- No abstract --

3 Guideline CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2015 EXECUTIVE SUMMARY. 2015

Garber, Alan J / Abrahamson, Martin Julian / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / Davidson, Michael B / Einhorn, Daniel / Garber, Jeffrey R / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul David / Umpierrez, Guillermo E / Anonymous2980851 / Anonymous2990851. · ·Endocr Pract · Pubmed #26642101.

ABSTRACT: This document represents the official position of the American Association of Clinical Endocrinologists and the American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician.

4 Guideline [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society]. 2015

Mata-Cases, M / Artola, S / Escalada, J / Ezkurra-Loyola, P / Ferrer-García, J C / Fornos, J A / Girbés, J / Rica, I / Anonymous970823. · ·Semergen · Pubmed #25752863.

ABSTRACT: In Spain, according to the Di@bet.es study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality. The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.

5 Guideline [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society]. 2015

Mata-Cases, M / Artola, S / Escalada, J / Ezkurra-Loyola, P / Ferrer-García, J C / Fornos, J A / Girbés, J / Rica, I / Anonymous4150822. · ·Aten Primaria · Pubmed #25735589.

ABSTRACT: In Spain, according to the Di@bet.es study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality. The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.

6 Guideline [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society]. 2015

Mata-Cases, M / Artola, S / Escalada, J / Ezkurra-Loyola, P / Ferrer-García, J C / Fornos, J A / Girbés, J / Rica, I / Anonymous6010819. · ·Endocrinol Nutr · Pubmed #25648701.

ABSTRACT: In Spain, according to the Di@bet.es study, 13.8% of the adult population suffers from diabetes and 14.8% from some form of prediabetes (impaired glucose tolerance, impaired fasting glucose or both). Since early detection of prediabetes can facilitate the implementation of therapeutic measures to prevent its progression to diabetes, we believe that preventive strategies in primary care and specialized clinical settings should be agreed. Screening for diabetes and prediabetes using a specific questionnaire (FINDRISC) and/or the measurement of fasting plasma glucose in high risk patients leads to detecting patients at risk of developing diabetes and it is necessary to consider how they should be managed. The intervention in lifestyle can reduce the progression to diabetes and reverse a prediabetic state to normal and is a cost-effective intervention. Some drugs, such as metformin, have also been shown effective in reducing the progression to diabetes but are not superior to non-pharmacological interventions. Finally, an improvement in some cardiovascular risk factors has been observed although there is no strong evidence supporting the effectiveness of screening in terms of morbility and mortality. The Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society has issued some recommendations that have been agreed by the Sociedad Española de Endocrinología y Nutrición, Sociedad Española de Endocrinología Pediátrica, Sociedad Española de Farmacia Comunitaria, Sociedad Española de Medicina Familiar y Comunitaria, Sociedad Española de Médicos Generales, Sociedad Española de Médicos de Atención Primaria, Sociedad Española de Medicina Interna, Asociación de Enfermería Comunitaria and Red de Grupos de Estudio de la Diabetes en Atención Primaria.

7 Guideline (5) Prevention or delay of type 2 diabetes. 2015

Anonymous1940816. · ·Diabetes Care · Pubmed #25537704.

ABSTRACT: -- No abstract --

8 Guideline Guidelines on the management and prevention of prediabetes. 2014

Anonymous3080819. · ·Acta Med Indones · Pubmed #25633555.

ABSTRACT: Pandemic obesity and diabetes mellitus (DM), particularly type-2 DM (T2DM) now has become a serious threat for people worldwide. The International Diabetes Federation (IDF) suggests that the prevalence of DM in the world is 1.9% and it has made DM as the 7th leading cause of death worldwide. It has been estimated that the prevalence of diabetes between 1994 and 2010 was projected as much as 215.6 milion people; however an evaluation in 2007 revealed that the number of diabetic patients has reached 246 million people and it has been concerned that the number would increase in 2025 reaching more than 300 million people. Patients with DM may have various complilcations, including macrovascular diseases (heart disease, stroke and peripheral vascular disease) and microvascular diseases (retinopathy, neuropathy and nephropathy). Complications of DM have started early before the diagnosis of DM has been made. About 50% of patients have alreadly had one chronic complication at the time of diagnosis. Therefore, it is necessary to have a guideline on management of prediabetes condition associated with prevention of chonic complication and cardiovascular risk of diabetes. The guideline is expected to improve the skills of health care professionals in recognizing prediabetes condition, identifying people at high risk for diabetes and providing an appropriate management so that the incidence and complication of DM can be reduced.

9 Guideline [Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases]. 2014

Motz, W / Kerner, W / Dörr, R / Anonymous2730812 / Anonymous2740812. ·Herz- und Diabeteszentrum Mecklenburg-Vorpommern, Klinikum Karlsburg, Klinikgruppe Dr. Guth GmbH & Co. KG, Greifswalder Str. 11, 17495, Karlsburg, Deutschland, motz@drguth.de. ·Herz · Pubmed #25416683.

ABSTRACT: Patients with type 2 diabetes mellitus have an increased cardiovascular risk compared with non-diabetics. The new guidelines provide physicians with orientation with respect to disorders in glucose metabolism and the risk of occurrence of cardiovascular diseases. An HBA1c level in the range of 6-8% is currently recommended, depending on cardiovascular comorbidities: in young diabetics 6% is recommended to avoid hypoglycemia and in older individuals with cardiovascular complications 8%. The target blood pressure given in the new guidelines is <140/85 mmHg. The guidelines still recommend bypass surgery instead of percutaneous coronary intervention (PCI) for diabetics; however, this recommendation is based on studies that do not reflect current practice and is disputable. Diagnostic measures and therapy of cardiac failure and arrhythmic disorders in the guidelines do not essentially differ between patients with and without diabetes, basically due to a lack of studies.

10 Guideline ISPAD Clinical Practice Consensus Guidelines 2014. Phases of type 1 diabetes in children and adolescents. 2014

Couper, Jennifer J / Haller, Michael J / Ziegler, Annette-G / Knip, Mikael / Ludvigsson, Johnny / Craig, Maria E / Anonymous4220809. · ·Pediatr Diabetes · Pubmed #25325095.

ABSTRACT: -- No abstract --

11 Guideline ISPAD Clinical Practice Consensus Guidelines 2014. Type 2 diabetes in the child and adolescent. 2014

Zeitler, Phil / Fu, Junfen / Tandon, Nikhil / Nadeau, Kristen / Urakami, Tatsuhiko / Barrett, Timothy / Maahs, David / Anonymous2140805. ·The Children's Hospital Colorado, Aurora, CO, USA. ·Pediatr Diabetes · Pubmed #25182306.

ABSTRACT: -- No abstract --

12 Guideline ISPAD Clinical Practice Consensus Guidelines 2014. Definition, epidemiology, and classification of diabetes in children and adolescents. 2014

Craig, Maria E / Jefferies, Craig / Dabelea, Dana / Balde, Naby / Seth, Anju / Donaghue, Kim C / Anonymous2130805. ·Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead and University of Sydney, Sydney, Australia; School of Women's and Children's Health, University of New South Wales, Sydney, Australia. ·Pediatr Diabetes · Pubmed #25182305.

ABSTRACT: -- No abstract --

13 Guideline ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. 2014

Anonymous3160793 / Anonymous3170793 / Rydén, Lars / Grant, Peter J / Anker, Stefan D / Berne, Christian / Cosentino, Francesco / Danchin, Nicolas / Deaton, Christi / Escaned, Javier / Hammes, Hans-Peter / Huikuri, Heikki / Marre, Michel / Marx, Nikolaus / Mellbin, Linda / Ostergren, Jan / Patrono, Carlo / Seferovic, Petar / Uva, Miguel Sousa / Taskinen, Marja-Riita / Tendera, Michal / Tuomilehto, Jaakko / Valensi, Paul / Zamorano, Jose Luis. · ·Diab Vasc Dis Res · Pubmed #24800783.

ABSTRACT: -- No abstract --

14 Guideline [ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD]. 2013

Anonymous4120777 / Rydén, Lars / Grant, Peter J / Anker, Stefan D / Berne, Christian / Cosentino, Francesco / Danchin, Nicolas / Deaton, Christi / Escaned, Javier / Hammes, Hans-Peter / Huikuri, Heikki / Marre, Michel / Marx, Nikolaus / Mellbin, Linda / Ostergren, Jan / Patrono, Carlo / Seferovic, Petar / Sousa Uva, Miguel / Taskinen, Marja-Riita / Tendera, Michał / Tuomilehto, Jaakko / Valensi, Paul / Zamorano, Jose Luis / Anonymous4130777. ·kardikardi@wp.pl. ·Kardiol Pol · Pubmed #24297732.

ABSTRACT: -- No abstract --

15 Guideline Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. 2013

Anonymous5350770 / Goldenberg, Ronald / Punthakee, Zubin. · ·Can J Diabetes · Pubmed #24070969.

ABSTRACT: -- No abstract --

16 Guideline ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). 2013

Anonymous3220768 / Rydén, Lars / Grant, Peter J / Anker, Stefan D / Berne, Christian / Cosentino, Francesco / Danchin, Nicolas / Deaton, Christi / Escaned, Javier / Hammes, Hans-Peter / Huikuri, Heikki / Marre, Michel / Marx, Nikolaus / Mellbin, Linda / Ostergren, Jan / Patrono, Carlo / Seferovic, Petar / Uva, Miguel Sousa / Taskinen, Marja-Riita / Tendera, Michal / Tuomilehto, Jaakko / Valensi, Paul / Zamorano, Jose Luis / Anonymous3230768 / Zamorano, Jose Luis / Achenbach, Stephan / Baumgartner, Helmut / Bax, Jeroen J / Bueno, Héctor / Dean, Veronica / Deaton, Christi / Erol, Cetin / Fagard, Robert / Ferrari, Roberto / Hasdai, David / Hoes, Arno W / Kirchhof, Paulus / Knuuti, Juhani / Kolh, Philippe / Lancellotti, Patrizio / Linhart, Ales / Nihoyannopoulos, Petros / Piepoli, Massimo F / Ponikowski, Piotr / Sirnes, Per Anton / Tamargo, Juan Luis / Tendera, Michal / Torbicki, Adam / Wijns, William / Windecker, Stephan / Anonymous3240768 / De Backer, Guy / Sirnes, Per Anton / Ezquerra, Eduardo Alegria / Avogaro, Angelo / Badimon, Lina / Baranova, Elena / Baumgartner, Helmut / Betteridge, John / Ceriello, Antonio / Fagard, Robert / Funck-Brentano, Christian / Gulba, Dietrich C / Hasdai, David / Hoes, Arno W / Kjekshus, John K / Knuuti, Juhani / Kolh, Philippe / Lev, Eli / Mueller, Christian / Neyses, Ludwig / Nilsson, Peter M / Perk, Joep / Ponikowski, Piotr / Reiner, Zeljko / Sattar, Naveed / Schächinger, Volker / Scheen, André / Schirmer, Henrik / Strömberg, Anna / Sudzhaeva, Svetlana / Tamargo, Juan Luis / Viigimaa, Margus / Vlachopoulos, Charalambos / Xuereb, Robert G. ·The disclosure forms of the authors and reviewers are available on the ESC website www.escardio.org/guidelines. ·Eur Heart J · Pubmed #23996285.

ABSTRACT: -- No abstract --

17 Guideline AACE comprehensive diabetes management algorithm 2013. 2013

Garber, Alan J / Abrahamson, Martin J / Barzilay, Joshua I / Blonde, Lawrence / Bloomgarden, Zachary T / Bush, Michael A / Dagogo-Jack, Samuel / Davidson, Michael B / Einhorn, Daniel / Garvey, W Timothy / Grunberger, George / Handelsman, Yehuda / Hirsch, Irl B / Jellinger, Paul S / McGill, Janet B / Mechanick, Jeffrey I / Rosenblit, Paul D / Umpierrez, Guillermo / Davidson, Michael H / Anonymous1270756. · ·Endocr Pract · Pubmed #23598536.

ABSTRACT: -- No abstract --

18 Guideline [Recommendations of care for patients with prediabetes]. 2012

Pelikánová, Terezie / Anonymous470723. ·diabetologie@email.cz ·Vnitr Lek · Pubmed #22486292.

ABSTRACT: -- No abstract --

19 Guideline Standards of medical care in diabetes--2011. 2011

Anonymous5370682. · ·Diabetes Care · Pubmed #21193625.

ABSTRACT: -- No abstract --

20 Editorial Nutrition and Chronic Conditions. 2019

Ojo, Omorogieva. ·Faculty of Education and Health, University of Greenwich, London SE9 2UG, UK. o.ojo@greenwich.ac.uk. ·Nutrients · Pubmed #30813286.

ABSTRACT: This editorial discusses and analyses the role of dietary interventions in the management of chronic conditions in recognition of the global increase of these diseases, the rise in the ageing population, and the significant cost to health services around the world. Evidence has shown that low-glycaemic index (GI) and low-carbohydrate diets are effective in the management of type 2 diabetes, and the role of unsaturated fatty acids, vitamins, and bioactive compounds in chronic disease management have been the subject of intense research. However, although multidimensional approaches are important in the management of these chronic conditions, nutritional interventions are critical and central to these strategies.

21 Editorial Prediabetes and Atherosclerotic Disease. 2019

Papazafiropoulou, Athanasia K / Patsourakos, Nikolaos G / Melidonis, Andreas. ·1 1st Department of Internal Medicine and Diabetes Center, Tzaneio General Hospital of Piraeus, Piraeus, Greece. · 2 Department of Cardiology, Tzaneio General Hospital of Piraeus, Piraeus, Greece. ·Angiology · Pubmed #30453746.

ABSTRACT: -- No abstract --

22 Editorial Macrophage Migration Inhibitory Factor-A Potential Target for Diabetes Prevention? 2018

Mokshagundam, Sri Prakash L. ·University of Louisville and Robley Rex VA Medical Center, Louisville, Kentucky. Electronic address: slmoks01@louisville.edu. ·Am J Med Sci · Pubmed #29680156.

ABSTRACT: -- No abstract --

23 Editorial Presymptomatic screening for autoimmune β-cell disorder: Baby steps toward prevention? 2018

Jacobsen, Laura M / Anhalt, Henry / Haller, Michael J. ·Division of Endocrinology, Department of Pediatrics, University of Florida, Gainesville, Florida. ·Pediatr Diabetes · Pubmed #29368416.

ABSTRACT: -- No abstract --

24 Editorial Engaging with Communities to Reduce Diabetes Development. 2017

Bolen, Shari D / Cebul, Randall D. ·Department of Medicine, MetroHealth Medical Center, Cleveland, OH, USA. sdb73@case.edu. · Center for Health Care Research and Policy, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA. sdb73@case.edu. · Better Health Partnership, Cleveland, OH, USA. sdb73@case.edu. · Department of Biostatistics and Epidemiology, Case Western Reserve University, Cleveland, OH, USA. sdb73@case.edu. · Department of Medicine, MetroHealth Medical Center, Cleveland, OH, USA. · Center for Health Care Research and Policy, Case Western Reserve University at MetroHealth Medical Center, Cleveland, OH, USA. · Better Health Partnership, Cleveland, OH, USA. · Department of Biostatistics and Epidemiology, Case Western Reserve University, Cleveland, OH, USA. ·J Gen Intern Med · Pubmed #28755099.

ABSTRACT: -- No abstract --

25 Editorial Editorial: The continuum of dysglycemia: Predicting progression from prediabetes to type 2 diabetes. 2017

Dagogo-Jack, Sam. ·Division of Endocrinology, Diabetes and Metabolism, University of Tennessee Health Science Center, Memphis, TN 38163, USA. Electronic address: sdj@uthsc.edu. ·J Diabetes Complications · Pubmed #28610946.

ABSTRACT: -- No abstract --

Next